Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > Oral Abstract Session II
View:
Post by 88STR8T on Nov 30, 2020 12:27pm

Oral Abstract Session II

I see this news to be significant because there are only 3 Oral Abstract Sessions over the 3 days and Dr. Witkowski is one of them.

Have a COVID FREE day!
Comment by Redbaron2211 on Nov 30, 2020 12:46pm
Also significant as its in the US presented by a highly regarded American Dr and institution.
Comment by Metalsguy1 on Nov 30, 2020 12:46pm
Your post is not very clear. An abstract is a brief and very concise presentation of data. An oral presentation is normally very comprehensive. I.E. abstracts are just trailers for upcoming movies. It isn't just that there are so few people selected for oral presentations, it is the fact that it is extremely difficult to be selected and the field is wide and so competitive. If the data is as ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities